RLAY - Relay Therapeutics Inc
10.69
0.550 5.145%
Share volume: 5,665,512
Last Updated: 03-10-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$10.14
0.55
0.05%
Summary score
37%
Profitability
43%
Dept financing
20%
Liquidity
58%
Performance
30%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 31-Dec-2021 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-9.56%
Return on assets
-9.83%
Return on sales
835696.37%
Return on invested capital
-342.73%
Total debt ratio
11.93%
Debt ratio change over timeo
-1.02%
Current Ratio
18.19%
Quick Ratio
17.91%
Cash Position Ratio
11.65%
Short-term ratios 31-Dec-2024 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-10.8%
Return on sales
-985.74%
Return on invested capital
0%
Total debt ratio
9.27%
Debt ratio change over timeo
0%
Current Ratio
20.57%
Quick Ratio
0%
Cash Position Ratio
2.87%
Last quarter ratios 31-Dec-2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-9.75%
Return on sales
-866.28%
Return on invested capital
0%
Total debt ratio
8.73%
Debt ratio change over time
0%
Current Ratio
22.61%
Quick Ratio
0%
Cash Position Ratio
3.28%
Performance ratios (change over 4 years) 31-Dec-2021 - 31-Dec-2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-98.5%
Return on assets
-98.1%
Return on sales
-386864.46%
Return on invested capital
-37.91%
Total debt ratio
-102.04%
Debt ratio change over time
-1.02%
Current Ratio
-4.24%
Quick Ratio
-3.87%
Cash Position Ratio
-3.64%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | RLAY | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | -9.56% | 0% | 5.97% | 8.91% |
| Return on assets | -9.83% | 2.97% | 3.34% | 2.04% |
| Return on sales | 835696.37% | 27.71% | 27.82% | 21.49% |
| Return on invested capital | -342.73% | 0% | 3.51% | 10.25% |
| Profitability | 25% | 22% | 50% | 65% |
| Total debt ratio | 11.93% | 93.27% | 65.75% | 43.64% |
| Debt ratio change over time | -1.02% | 14.34% | 187.33% | 9.75% |
| Dept financing | 3% | 27% | 43% | 13% |
| Current Ratio | 20.57% | 1.22% | 1.42% | 2.33% |
| Quick Ratio | 0% | 0.94% | 1.27% | 1.72% |
| Cash Position Ratio | 2.87% | 0.39% | 0.58% | 0.86% |
| Liquididy | 75% | 6% | 5% | 7% |
| Short-term ratios | RLAY | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -10.8% | 3.27% | 4.7% | 1.36% |
| Return on sales | -985.74% | 24.35% | 34.09% | 15.11% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 35% | 50% | 18% |
| Total debt ratio | 9.27% | 91.09% | 63.87% | 38.21% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 28% | 25% | 18% | 10% |
| Current Ratio | 20.57% | 1.22% | 1.42% | 2.33% |
| Quick Ratio | 0% | 0.94% | 1.27% | 1.72% |
| Cash Position Ratio | 2.87% | 0.39% | 0.58% | 0.86% |
| Liquididy | 50% | 19% | 25% | 35% |